Pharmacists in Newberg, Oregon


29 Pharmacists found in Newberg
female pharmacist

Kristin Denning, PHARMD


Pharmacist
3300 Portland Rd, Newberg, OR 97132
503-537-1383     503-537-1377

male pharmacist

Kurt Schluter


Pharmacist
3300 Portland Rd, St 100, Newberg, OR 97132
503-537-1383     503-537-1377

female pharmacist

Dr. Paula Jo Mistowski, PHARMD


Pharmacist
1150 N Springbrook Rd, Newberg, OR 97132
503-538-7402    



male pharmacist

Mr. Peter Shawn Toomey


Pharmacist
1140 N Springbrook Rd, Newberg, OR 97132
503-538-2430    

female pharmacist

Que Phung Thi Nguyen


Pharmacist
2900 Haworth Ave, Newberg, OR 97132
503-538-0691    

male pharmacist

Rick Mai


Pharmacist
3300 Portland Rd, Suite 100, Newberg, OR 97132
503-537-1383    

female pharmacist

Dr. Sarah Choi, PHARMD


Pharmacist
1840 Portland Rd, Newberg, OR 97132
503-538-9360    

female pharmacist

Susan L Wong


Pharmacist
3300 Portland Rd, Newberg, OR 97132
503-537-1383    

female pharmacist

Susanna Lyn Dube, PHARM D


Pharmacist
3300 Portland Rd, Newberg, OR 97132
503-537-1383     503-537-1377

female pharmacist

Thuy Linh Bui, RPH


Pharmacist
1840 Portland Rd, Newberg, OR 97132
503-538-9360     503-538-9261

female pharmacist

Dr. Tiffanie Anne Hartman, RPH


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
3300 E Portland Rd, Newberg, OR 97132
503-537-1383     503-537-1337

female pharmacist

Tracee Elizabeth Mock, PHARMD


Pharmacist
1001 N Providence Dr, Newberg, OR 97132
503-537-1555    

female pharmacist

Ussah Manyrath


Pharmacist
1150 N Springbrook Rd, Newberg, OR 97132
503-538-7402    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.